BGI Genomics Monthly Spotlight - March 2024
BGI Genomics
BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing services.
Advancing Healthcare in Uzbekistan: BGI Genomics CEO's Vision Shared on Uzbekistan's National Television
Zhao Lijian, CEO of BGI Genomics, provided fresh insights on the company's vision during the exclusive interview with Uzbekistan's National Television on Channel O'zbekiston24. He highlighted BGI Genomics' commitment to bolstering health outcomes through precision medicine and advanced genetic testing solutions.
Deciphering Genetic Testing for Hereditary Cancer Diagnosis
In the "Advancing Precision Oncology Through Genetic Panels: Comprehensive Evaluation and Patient-Centric Care" webinar, experts Dr. Benjamin Garcia-Bloj , Dr. Ahmet ULUDAĞ and Professor Gary Lu shared crucial insights shaping the future of precision oncology and relevant case studies.
Enhancing High-risk Infant Outcomes with Newborn Genetic Screening in China
The study led by Xin Wang and Yun Sun from the Nanjing Maternity and Child Health Care Hospital was recently published in the Journal of Global Health. It highlighted newborn genetic screening (NBGS) as a more comprehensive and accurate approach relative to traditional newborn screening method.
From China to Uzbekistan - United for Women's Wellness on IWD
On the occasion of International Women's Day (IWD), BGI Genomics interviewed Wang Leilei, a trailblazing blind model, and Viktoriya Tsay, an Uzbek advocate of women's health. Their journeys inspire us to empower women's health worldwide with precision medicine and unwavering support.
BGI Genomics making waves at Pathology Update 2024
BGI Genomics Australia Team had a great time at Pathology Update in Adelaide. Albert Hsing and Ben Le Gros showcased our cutting-edge clinical services like VISTA™, NIFTY®, and NOVA™ while reinforcing our commitment to advancing the world of genomics and enhancing health outcomes in Australia and worldwide.